Breakthrough scientist recognised as one of Europe's best

The European Molecular Biology Organisation (EMBO) is made up of over 1500 leading researchers from across Europe with a focus on promoting...

6 May 2014

Report claims that people are being diagnosed with cancer too late

Dr Caitlin Palframan, Senior Policy Manager for Breakthrough Breast Cancer, said: “Macmillan’s report highlights the alarming reality that there...

2 May 2014

Reducing just six risk factors could prevent 37 million deaths in 15 years

Eluned Hughes, Senior Manager – Information, at Breakthrough Breast Cancer says: “We have known for some time that these risk factors play a...

2 May 2014

Secondary Breast Cancer Pledge launched by Barts Health NHS Trust

The Trust has signed up to the Secondary Breast Cancer Pledge, committing it to providing the best possible care to patients diagnosed with secondary...

28 April 2014

Kadcyla, revolutionary new drug for secondary breast cancer, rejected by NICE

Kadcyla, also referred to as trastuzumab emtansine, or T-DM1, is a unique combination drug made up of trastuzumab (Herceptin) and a very potent...

22 April 2014

Scientists find new exploitable weakness in cancer cells

Researchers at The Institute of Cancer Research, London, proved for the first time that a group of proteins known as the anaphase-promoting complex (...

16 April 2014

Stars come out to celebrate Fashion Targets Breast Cancer

The party took place at the St Pancras Renaissance Hotel with fellow Fashion Targets Breast Cancer ambassadors Antonia O’Brien, Rosie Fortescue,...

11 April 2014

New genetic insight into the origins of breast cancer

New research led by scientists at the Wellcome Trust Sanger Institute in Cambridge, and part-funded by Breakthrough Breast Cancer, has provided...

11 April 2014

High fat diet increases breast cancer risk

Eluned Hughes, Senior Manager - Information at Breakthrough Breast Cancer, said: “This is an important finding because it's difficult to unpick...

10 April 2014